Functional symptoms in clinically definite MS--pseudo-relapse syndrome

A Merwick1, B J Sweeney

  • 1Department of Clinical Neurology, Cork University Hospital, Wilton, Cork, Ireland. ainemerwick@yahoo.co.uk

International MS Journal
|September 11, 2008
PubMed

Insights

Diagnosing multiple sclerosis (MS) relapses can be challenging, especially in emergency settings. Misclassifying functional symptoms as MS relapses poses risks, highlighting the need for careful assessment.

Area of Science:

  • Neurology
  • Clinical Medicine

Background:

  • Multiple Sclerosis (MS) diagnosis relies on formalized criteria and Magnetic Resonance Imaging (MRI).
  • Assessing acute neurological episodes can be difficult, particularly outside standard clinical settings or working hours.
  • Emergency department physicians may lack specialized neurological training and face time constraints.

Observation:

  • Acute episodes in MS patients may not always correlate with specific MRI lesions.
  • Functional symptoms can be misidentified as true MS relapses due to diagnostic challenges.
  • Three clinical vignettes illustrate potential scenarios of pseudo-relapse in MS.

Findings:

  • Misclassification of functional symptoms as MS relapses carries significant risks.
  • Functional symptoms can be multifactorial and contribute to disease burden.
  • Accurate diagnosis is crucial to avoid unnecessary harm and manage patient care effectively.

Implications:

  • A multidisciplinary approach is recommended for evaluating episodes of clinical deterioration in MS patients.
  • Improved diagnostic strategies are needed to differentiate true relapses from functional symptoms.
  • Recognizing pseudo-relapse is essential for appropriate patient management and minimizing iatrogenic harm.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...